There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...

AtaCor, a cardiac rhythm management (CRM) company, develops extravascular defibrillation technologies. Its offerings aim to ...

A new study published by cardiologists indicates that the iPhone 12 can interfere with implantable cardioverter defibrillators (or ICDs) if the phone is placed close to a patient’s heart. But the ...

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the ...

Pacemakers and defibrillators have a growing use in pediatrics and in patients with congenital heart disease, but they present unique problems and implications for their implantation and follow-up.

Cleveland Clinic doctors were the first in the world to successfully implant leadless pacemaker defibrillator systems in two patients as part of a global clinical trial sponsored by Boston Scientific, ...

Medtronic has competition in the U.S. market for leadless pacemakers. The Dublin, Ireland-based company made history nearly six years ago to the day when FDA approved the Micra leadless pacemaker on ...